References
- 1. CDC. The Health Effects of Overweight and Obesity. Available at: https://www.cdc.gov/healthyweight/effects/index.html
- 2. Akram H, Ashraf G, Ijaz MA. The Impacts of Complex Social, Environmental, and Behavioral Factors on Obesity. International Journal of Basic Science in Medicine. 2018;3:94-98.10.15171/ijbsm.2018.17
- 3. WHO. Obesity and Overweight. Available at: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight
- 4. CDC. Adult Obesity Facts. Available at: https://www.cdc.gov/obesity/data/adult.html
- 5. WHO Global Health Observatory data repository. Prevalence of obesity among adults, BMI ≥ 30, age-standardized. Estimates by WHO region. Available at: http://apps.who.int/gho/data/view.main.REGION2480A
- 6. Badran M, Laher I. Obesity in Arabic-speaking countries. J Obes. 2011;2011:686430.10.1155/2011/686430322834022175002
- 7. Al-Thani MH, Al-Thani AA, Al-Chetachi WF, et al. Dietary and nutritional factors influencing obesity in Qatari adults and the modifying effect of physical activity. Journal of Obesity and Weight-loss Medication. 2015;1:007.10.23937/2572-4010.1510007
- 8. Klautzer L, Becker J, Mattke S. The curse of wealth – Middle Eastern countries need to address the rapidly rising burden of diabetes. Int J Health Policy Manag. 2014;2:109.10.15171/ijhpm.2014.33399278424757686
- 9. Al-Thani M, Al-Thani AA, Al-Chetachi W, et al. Situation of diabetes and related factors among Qatari adults: findings from a community-based survey. JMIR Diabetes. 2017;2:e7.10.2196/diabetes.7535623885230291095
- 10. Al-Thani M, Al-Thani AA, Al-Mahdi N, et al. An overview of food patterns and diet quality in Qatar: findings from the National Household Income Expenditure Survey. Cureus. 2017;9:e1249.10.7759/cureus.1249547239728630807
- 11. Al-Thani M, Al-Thani A, Al-Chetachi W, Akram H. Obesity and related factors among children and adolescents in Qatar. Int J Basic Sci Med. 2017;2:161-165.10.15171/ijbsm.2017.30
- 12. Kerkadi A, Sadig AH, Bawadi H, et al. The relationship between lifestyle factors and obesity indices among adolescents in Qatar. Int J Environ Res Public Health. 2019;16:4428.10.3390/ijerph16224428688835231766192
- 13. Kerkadi A, Hassan AS, Al Chetachi W, et al. Prevalence of general and abdominal obesity among adolescents attending independent schools in Qatar. Nutrition & Food Science. 2019;49:687-699.10.1108/NFS-09-2018-0260
- 14. Al-Thani M, Al-Thani A, Alyafei S, et al. The prevalence and characteristics of overweight and obesity among students in Qatar. Public Health. 2018;160:143-149.10.1016/j.puhe.2018.03.02029704956
- 15. Murphy M, Robertson W, Oyebode O. Obesity in international migrant populations. Curr Obes Rep. 2017;6:314-323.10.1007/s13679-017-0274-7557906528755178
- 16. Gele AA, Mbalilaki AJ. Overweight and obesity among African immigrants in Oslo. BMC Research Notes. 2013;6:119.10.1186/1756-0500-6-119361799923531273
- 17. Sharifi N, Mahdavi R, Ebrahimi-Mameghani M. Perceived barriers to weight loss programs for overweight or obese women. Health Promot Perspect. 2013;3:11-22.
- 18. Serour M, Alqhenaei H, Al-Saqabi S, Mustafa AR, Ben-Nakhi A. Cultural factors and patients’ adherence to lifestyle measures. British Journal of General Practice. 2007;57:291-295.
- 19. Middleton KR, Anton SD, Perri MG. Long-term adherence to health behavior change. American Journal of Lifestyle Medicine. 2013;7:395-404.10.1177/1559827613488867498840127547170
- 20. Al-Thani M, Al-Thani A, Alyafei S, et al. Prevalence of physical activity and sedentary-related behaviors among adolescents: data from the Qatar National School Survey. Public Health. 2018;160:150-155.10.1016/j.puhe.2018.03.01929704957
- 21. Andajani-Sutjahjo S, Ball K, Warren N, Inglis V, Crawford D. Perceived personal, social and environmental barriers to weight maintenance among young women: A community survey. Int J Behav Nutr Phys Act. 2004;1:15.10.1186/1479-5868-1-1552436715462679
- 22. Higuera-Hernández MF, Reyes-Cuapio E, Gutiérrez-Mendoza M, et al. Fighting obesity: Non-pharmacological interventions. Clinical Nutrition ESPEN. 2018;25:50-55.10.1016/j.clnesp.2018.04.00529779818
- 23. Mayer MA, Hocht C, Puyó A, Taira CA. Recent advances in obesity pharmacotherapy. Current Clinical Pharmacology. 2009;4:53-61.10.2174/15748840978723612819149502
- 24. Mayo Clinic. Healthy Lifestyle, Weight loss. Available at: https://www.mayoclinic.org/healthy-lifestyle/weight-loss/in-depth/weight-loss-drugs/art-20044832
- 25. Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA. 2014;311:74-86.10.1001/jama.2013.281361392867424231879
- 26. Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:342-362.10.1210/jc.2014-341525590212
- 27. O’Brien P. Surgical Treatment of Obesity. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000.
- 28. Valezi AC, Herbella FA. Historical Notes on the Surgical Treatment of Morbid Obesity. In: Foregut Surgery. Cham: Springer, 2020; p. 219-226.10.1007/978-3-030-27592-1_23
- 29. Peterson CT, Denniston K, Chopra D. Therapeutic uses of triphala in ayurvedic medicine. J Altern Complement Med. 2017;23:607-614.10.1089/acm.2017.0083556759728696777
- 30. Mohammad K, Larijani B. A systematic review of the antioxidant, anti-diabetic, and anti-obesity effects and safety of triphala herbal formulation. J Med Plants Res. 2013;7:831-844.
- 31. Kamali SH, Khalaj AR, Hasani-Ranjbar S, et al. Efficacy of ‘Itrifal Saghir’, a combination of three medicinal plants in the treatment of obesity; A randomized controlled trial. DARU. 2012;20:33.10.1186/2008-2231-20-33355901423351558
- 32. Namazi N, Larijani B, Ayati MH, Abdollahi M. The effects of Nigella sativa L. on obesity: A systematic review and meta-analysis. J Ethnopharmacol. 2018;219:173-181.10.1016/j.jep.2018.03.00129559374
- 33. Tavakkoli A, Mahdian V, Razavi BM, Hosseinzadeh H. Review on clinical trials of black seed (Nigella sativa) and its active constituent, thymoquinone. J Pharmacopuncture. 2017;20:179.10.3831/KPI.2017.20.021563367030087794
- 34. Esteghamati A, Mazaheri T, Rad MV, Noshad S. Complementary and alternative medicine for the treatment of obesity: a critical review. Int J Endocrinol Metab. 2015;13: e19678.10.5812/ijem.19678438622825892995
- 35. Allison DB, Fontaine KR, Heshka S, Mentore JL, Heymsfield SB. Alternative treatments for weight loss: a critical review. Crit Rev Food Sci Nutr. 2001;41:1-28.10.1080/2001409109166111152041
- 36. Icken D, Feller S, Engeli S, et al. Caffeine intake is related to successful weight loss maintenance. Eur J Clin Nutr. 2016;70:532-534.10.1038/ejcn.2015.18326554757
- 37. U.S Food & Drug Administration. Medical Devices for Weight Loss and Weight Management: What to Know. Available at: https://www.fda.gov/consumers/consumer-updates/medical-devices-weight-loss-and-weight-management-what-know
- 38. Gordon K, Steele Gray C, Dainty KN, DeLacy J, Ware P, Seto E. Exploring an Innovative Care Model and Telemonitoring for the Management of Patients With Complex Chronic Needs: Qualitative Description Study. JMIR Nursing. 2020;3:e15691.10.2196/15691827944234345777
- 39. Akram H, Aslam F. An Overview of Disease Burden, Mechanism, Traditional and Non-traditional Management of Type 2 Diabetes. Journal of Interdisciplinary Medicine. 2019;4:124-131.10.2478/jim-2019-0016
- 40. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Available at: https://apps.who.int/iris/handle/10665/44203
- 41. Shakoori IS, Aslam F, Ashraf G, Akram H. Understanding chronic disease risk factors and multimorbidity. Int J Community Med Public Health. 2020;7:1990-1993.10.18203/2394-6040.ijcmph20201556
- 42. CDC. Coronavirus Disease 2019 (COVID-19).Groups at Higher Risk for Severe Illness. Available at: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.html
- 43. WebMD. Obesity New Risk Factor for Young COVID Patients. Available at: https://www.webmd.com/lung/news/20200429/obesity-new-risk-factors-for-young-covid-patients